Dr. Reddy’s Laboratories shares rallied strongly on Thursday, rising nearly 7% in morning trade even as the broader market remained under pressure.
The stock was trading at Rs 1,295.10, up Rs 80 or 6.42% at around 10:01 am on the Bombay Stock Exchange (BSE), sharply outperforming benchmark indices that were deep in the red.
The sharp move made Dr. Reddy’s Laboratories one of the top gainers on the Nifty 50 at a time when the Sensex and Nifty had fallen sharply.
WHY IS DR REDDY’S STOCK RISING TODAY?
There was no immediate company-specific announcement visible in public filings during market hours that fully explained the sharp jump, suggesting the rally may be driven by a mix of sectoral and market factors.
The biggest factor appears to be defensive buying in pharmaceutical stocks.
When markets turn volatile, investors often move money into pharma and healthcare companies because their earnings are generally seen as steadier than cyclical sectors such as autos, metals or financials.
That pattern was visible on Thursday, with other pharma names also trading higher. Cipla gained around 1.65%, while Sun Pharmaceutical Industries was also in the green earlier in the session.
Rising crude oil prices above $100 per barrel and concerns over the economic impact of the West Asia conflict have increased risk aversion in equities, making defensive sectors more attractive.
WHY DR REDDY MAY BE LEADING THE RALLY
Among pharma names, Dr. Reddy’s Laboratories is a liquid large-cap stock with a strong presence in export markets, especially the United States.
Such stocks often attract institutional buying during uncertain market phases.
Traders also said the sharp rise could be getting amplified by short covering, where investors betting on declines rush to close positions as the stock moves higher.
WHAT INVESTORS SHOULD WATCH NOW
Market participants will track whether the stock sustains gains near the Rs 1,300 mark through the session.
Investors will also watch for any exchange filings, analyst commentary or sector updates that could offer more clarity on the trigger.
If volatility remains high in the broader market, pharma stocks such as Dr. Reddy’s Laboratories could remain in focus as defensive bets.
